Boeing Company (The)(BA) - Stock detail

Boeing Company (The)

US
BA
The Boeing Company(Listing date: 09/05/1934)

The Boeing Company was originally incorporated in the state of Washington in 1916 and in Delaware in 1934. The company is a global market leader in the design, development, manufacture, sale, service and support of commercial jetliners, military aircraft, satellites, missile defense, human spaceflight, and launch systems and services. It is one of the two manufacturers of commercial aircraft with more than 100 seats in the global commercial aviation industry and one of the largest defense contractors in the United States.

AI Value AnalystSell
Overall Rating2.3/10
Generated at:2026-06-03 17:40:44
Analysis based on 5 financial reports from 2025-03-31 to 2026-03-31. Data includes quarterly and annual financial statements, real-time market data as of 2026-06-04, and trailing twelve month (TTM) metrics. Data completeness: Comprehensive financial analysis covering balance sheet, income statement, and key ratios. Source: Company financial reports and market data.
Overview

Boeing Company (The) (BA) is a global aerospace and defense leader operating through Commercial Airplanes, Defense, Space & Security, and Global Services segments. The fundamental analysis reveals a company with significant financial risks, unstable profitability, and extreme overvaluation based on current metrics. While revenue shows strong recovery, the company's high leverage, poor liquidity, and inconsistent earnings create a fragile financial condition.

Valuation
2/10
Profitability
3/10
Financial health
2/10
Operation Advice
  • Based on fundamental analysis, Boeing stock (BA) is overvalued at $210.58.
  • Investors should sell at current levels and wait for a more attractive entry point.
  • A fundamental target price of approximately $175 is suggested based on a path to improved margins and reduced risk.
  • Consider re-evaluating if the stock price falls to the $140-$190 range and the company demonstrates sustained profitability improvement and debt reduction.

Valuation

P/E TTM
75.67
P/E LYR
79.59
P/B MRQ
28.66
P/S TTM
--
AI Analysis
  • The stock is trading at a significant premium based on traditional valuation metrics. Current price of $210.58 appears overvalued relative to current profitability, with extremely high P/E (79.59) and P/B (28.66) ratios. Valuation is supported by expectations of future recovery rather than present fundamentals.
  • Current Market Price: $210.58 (as of 2026-06-04)
  • Price-to-Earnings (P/E): Dynamic PE of 79.59 and PE-TTM of 75.67 are extremely high
  • Price-to-Book (P/B): P/B ratio of 28.66 is extraordinarily high
  • Price-to-Sales (P/S): P/S-TTM of 1.80 is a more grounded metric
  • The stock is trading at a significant premium based on traditional valuation metrics (P/E, P/B)
  • The current price of $210.58 appears to be overvalued relative to its current and recent profitability
  • The valuation is entirely supported by expectations of a strong multi-year recovery, improved execution, and debt reduction
  • A reasonable fundamental price range of approximately $140 to $190
  • A fundamental target price based on a path to improved margins and reduced risk would be in the upper half of this range, around $175
Valuation trend

Profitability

ROE TTM
288.04%
Net margin
-0.03%
Gross margin
11.46%
Total revenue
22.22B
AI Analysis
  • Profitability shows a company in volatile recovery with underlying challenges. While revenue is recovering robustly, the company struggles to translate this into consistent, healthy profits. Margins remain thin and earnings are highly volatile.
  • Revenue Growth: 34.50% year-over-year increase in annual revenue for 2025 and 13.96% increase in Q1 2026
  • Profit Margins: Net margin for full year 2025 was 2.50%, but turned negative again in Q1 2026 (-0.03%)
  • Gross margin of 11.46% in Q1 2026 is low for a manufacturing company
  • Return on Equity: ROE-TTM of 288.04% is an extreme outlier distorted by very small shareholder equity base
  • Earnings Volatility: Historical data shows wild swings in quarterly net income
  • The company struggles to translate revenue recovery into consistent, healthy profits
  • Profitability is weak, margins are thin, and earnings are highly volatile
Profitability
2025Q12025Q22025Q32025Q42026Q1
ROE TTM--17.99%98.45%289.13%288.04%
Earnings
2025Q12025Q22025Q32025Q42026Q1
Total revenue19.50B42.24B65.52B89.46B22.22B

Financial health

Debt/Asset
96.37%
Current ratio
1.18
Quick ratio
0.35
Cash ratio
0.35
AI Analysis
  • Financial health presents significant concerns with high leverage, weak liquidity, and poor asset efficiency. The company is highly indebted with minimal equity cushion and suffers from poor liquidity, posing substantial risks to operational stability.
  • High Leverage: 96.37% Debt-to-Asset ratio indicates extremely high financial leverage with minimal equity cushion
  • Weak Liquidity: Current Ratio of 1.18 is just above minimum threshold, suggesting limited short-term liquidity
  • Quick Ratio of 0.35 is critically low, indicating severe shortage of liquid assets to cover current liabilities
  • Asset Efficiency: Return on Assets (ROA-TTM) of 1.40% is very low, suggesting inefficient use of asset base
  • The financial condition is fragile
  • The company is highly indebted and suffers from poor liquidity
  • Poses substantial risks to its operational stability and financial flexibility
Leverage
2025Q12025Q22025Q32025Q42026Q1
Debt/Asset102.12%102.12%105.50%96.76%96.37%
Liquidity
2025Q12025Q22025Q32025Q42026Q1
Current ratio1.231.231.181.191.18